Cell Source, Inc. (CLCS)
Cell Source, Inc. (CLCS)
For the quarter ending 2025-03-31, CLCS has $292,446 in assets. $20,428,481 in debts.
| Balance Sheets | 2025-03-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Cash | 1,240 | 74,631 | ||
| Prepaid expenses | 80,375 | 160,750 | ||
| Subscription receivable | - | 50,000 | ||
| Prepaid expenses - research and development | 209,427 | - | ||
| Other current assets | 1,404 | 1,119 | ||
| Total assets | 292,446 | 286,500 | ||
| Accounts payable | 1,929,223 | 1,888,729 | ||
| Accrued expenses-Nonrelated Party | 1,441,697 | 1,115,501 | ||
| Accrued expenses-Related Party | 217,000 | 202,500 | ||
| Accrued interest-Nonrelated Party | 1,168,356 | 1,060,408 | ||
| Accrued interest-Related Party | 2,193,741 | 2,123,531 | ||
| Accrued compensation | 1,092,413 | 1,067,777 | ||
| Notes payable-Nonrelated Party | 1,177,343 | 1,175,864 | ||
| Notes payable-Related Party | 795,345 | 443,750 | ||
| Convertible notes payable-Nonrelated Party | 966,707 | 986,500 | ||
| Convertible notes payable-Related Party | 7,561,708 | 7,461,708 | ||
| Warrant liabilities-Nonrelated Party | 89,118 | - | ||
| Warrant liabilities-Related Party | 131,792 | - | ||
| Derivative liabilities-Nonrelated Party | 543,997 | 479,844 | ||
| Derivative liabilities-Related Party | 151,228 | 101,659 | ||
| Financing liability | 314,985 | 314,985 | ||
| Advances payable - related party-Nonrelated Party | 194,375 | 194,375 | ||
| Advances payable - related party-Related Party | 100,000 | 200,000 | ||
| Accrued dividend payable | 359,453 | 7,205 | ||
| Total liabilities | 20,428,481 | 18,824,336 | ||
| Preferred stock, value-Series AConvertible Preferred Stock | 1,342 | 1,342 | ||
| Preferred stock, value-Series BConvertible Preferred Stock | 267 | 267 | ||
| Preferred stock, value-Series CConvertible Preferred Stock | 537 | 537 | ||
| Common stock, 0.001 par value, 200,000,000 shares authorized 45,038,244 shares issued and outstanding as of march 31, 2025 and december 31, 2024 | 45,038 | 45,038 | ||
| Additional paid-in capital | 27,478,662 | 27,595,010 | ||
| Accumulated deficit | -47,661,881 | -46,180,030 | ||
| Total stockholders deficiency | -20,136,035 | -18,537,836 | ||
| Total liabilities and stockholders deficiency | 292,446 | 286,500 | ||